Hematologic abnormalities in severe neonatal necrotizing enterocolitis: 25 years later.

Area of Science:

• Neonatal Medicine
• Hematology
• Pediatric Surgery

Background:

• Necrotizing enterocolitis (NEC) is a critical neonatal surgical emergency.
• Hematological abnormalities associated with NEC have been recognized for 25 years.
• Existing treatments for NEC do not fully address secondary hematopoietic issues.

Purpose of the Study:

• To review current knowledge on NEC-associated hematological pathophysiology.
• To examine disturbances in megakaryocytopoiesis, coagulation, leukopoiesis, and erythropoiesis in NEC.
• To discuss potential therapeutic strategies for these secondary hematopoietic problems.

Main Methods:

• Literature review of existing studies on NEC and hematological manifestations.
• Analysis of current understanding of NEC pathophysiology.
• Synthesis of information on hematopoietic disturbances secondary to NEC.

Main Results:

• NEC significantly impacts multiple hematopoietic lineages, including platelet production (megakaryocytopoiesis).
• Coagulation abnormalities are common in NEC, increasing bleeding risks.
• Disruptions in white blood cell (leukopoiesis) and red blood cell (erythropoiesis) production are also observed.

Conclusions:

• NEC triggers complex hematological changes affecting various blood cell types.
• Understanding these disturbances is crucial for comprehensive NEC management.
• Targeted therapies for NEC-induced hematological issues may improve patient outcomes.